Open AccessErratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
Author(s) -
Akio Kaito,
Takeshi Kuwata,
Masanori Tokunaga,
Kohei Shitara,
Reo Sato,
Tetsuo Akimoto,
Takahiro Kinoshita
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i21.5494
Subject(s) - medicine , human epidermal growth factor receptor 2 , epidermal growth factor receptor , cancer , oncology , human stomach , epidermal growth factor , receptor , cancer research , stomach , breast cancer
[This corrects the article on p. 1964 in vol. 7, PMID: 31423428.].